ロード中...
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Over the past few years, multiple immune checkpoint blockers (ICBs) have achieved unprecedented clinical success and have been approved by regulatory agencies for the treatment of an increasing number of malignancies. However, only a limited fraction of patients responds to ICBs employed as a standa...
保存先:
| 出版年: | Semin Cancer Biol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004231/ https://ncbi.nlm.nih.gov/pubmed/29258856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2017.12.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|